InvestSMART

Recce Pharmaceuticals Ltd (ASX: RCE) - Announcements

- Current share price for RCE : $0.365

ASX company news and announcements for Recce Pharmaceuticals Ltd (RCE) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Recce Pharmaceuticals Ltd (RCE) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Recce Pharmaceuticals Ltd (RCE), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Recce Pharmaceuticals Ltd (RCE)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$109 Investor Webinar - Q4 FY26 Investor Presentation Deck 21 Jul 2026 12:50PM $0.363 $0.365 risen by 0.69%
$109 Investor Webinar - 2.30PM (AEST) 21 July 2026 21 Jul 2026 12:27PM $0.355 $0.365 risen by 2.82%
$109 Quarterly Activities/Appendix 4C Cash Flow Report 21 Jul 2026 12:20PM $0.355 $0.365 risen by 2.82%
$109 Update - Proposed issue of securities - RCE 20 Jul 2026 9:33AM $0.380 $0.365 fallen by 3.95%
$109 Extension to Share Purchase Plan Closing Date 20 Jul 2026 9:29AM $0.380 $0.365 fallen by 3.95%
$109 Vietnamese Patent Granted for RECCE Anti-Infectives 14 Jul 2026 8:56AM $0.390 $0.365 fallen by 6.41%
$109 Share Purchase Plan - Letter and Offer Booklet 6 Jul 2026 9:06AM $0.375 $0.365 fallen by 2.67%
$109 Cleansing Notice 3 Jul 2026 2:31PM $0.370 $0.365 fallen by 1.35%
$109 Application for quotation of securities - RCE 3 Jul 2026 2:25PM $0.370 $0.365 fallen by 1.35%
$109 Notification of cessation of securities - RCE 2 Jul 2026 4:26PM $0.375 $0.365 fallen by 2.67%
$109 Cleansing Notice 1 Jul 2026 11:30AM $0.385 $0.365 fallen by 5.19%
$109 Application for quotation of securities - RCE 1 Jul 2026 11:24AM $0.395 $0.365 fallen by 7.59%
$109 Application for quotation of securities - RCE 1 Jul 2026 11:10AM $0.385 $0.365 fallen by 5.19%
$109 Application for quotation of securities - RCE 1 Jul 2026 11:04AM $0.375 $0.365 fallen by 2.67%
$109 AUD $3.7M Income Tax Refund Received 1 Jul 2026 9:07AM $0.405 $0.365 fallen by 9.88%
$109 Proposed issue of securities - RCE 26 Jun 2026 6:00PM $0.400 $0.365 fallen by 8.75%
$109 RCE Investor Presentation 26 Jun 2026 10:35AM $0.375 $0.365 fallen by 2.67%
$109 Proposed issue of securities - RCE 26 Jun 2026 10:19AM $0.460 $0.365 fallen by 20.65%
$109 Placement & SPP to raise $8 million 26 Jun 2026 10:03AM $0.460 $0.365 fallen by 20.65%
$109 Trading Halt 24 Jun 2026 10:08AM $0.460 $0.365 fallen by 20.65%
$109 Pause in Trading 24 Jun 2026 9:54AM $0.460 $0.365 fallen by 20.65%
$109 HREC Approval Accelerates Global Phase 3 DFI Strategy 22 Jun 2026 10:03AM $0.485 $0.365 fallen by 24.74%
$109 Addendum to Recce Signs Middle East Licensing Term Sheet 27 May 2026 1:49PM $0.580 $0.365 fallen by 37.07%
$109 Recce Signs Middle East Licensing Term Sheet 27 May 2026 9:48AM $0.525 $0.365 fallen by 30.48%
$109 Quarterly Activities/Appendix 4C Cash Flow Report 30 Apr 2026 5:03PM $0.480 $0.365 fallen by 23.96%

1 - 25 of 717 results

Page 1 of 29

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.